Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital... Show more
Marsh & McLennan Companies, Inc. (rebranded as "Marsh" in January 2026) is a global professional services leader spanning risk, reinsurance and capital, people and investments, and management consulting, advising clients across roughly 130 countries. Its diversified model — combining the Marsh Risk brokerage, Guy Carpenter reinsurance business, Mercer benefits and wealth consulting, and management consulting — provides a structurally defensive revenue base while offering multiple avenues for organic growth.
The firm's medium-term positioning rests on two pillars. First, its scale and data advantage in a world of increasingly complex and interconnected risk — from cyber and climate to geopolitical disruption — supports durable advisory demand even as insurance pricing softens. Second, its deliberate shift toward higher-growth, higher-margin services, particularly technology-driven consulting and AI-enabled analytics, is intended to lift the overall growth profile. The rebranding to a unified "Marsh" identity also reflects an effort to consolidate brand equity and cross-sell across previously siloed units.
Competitively, Marsh competes with peers such as Aon, Willis Towers Watson, and Gallagher, where market share is often won through specialist expertise, data tools, and global reach rather than price alone. Its ongoing acquisition strategy — including the sizable McGriff transaction and smaller capability-focused deals — complements organic growth by adding regional density and specialized talent.
Several upcoming events could materially shape investor sentiment. The next quarterly earnings release remains the most immediate catalyst, given that Marsh has beaten consensus in each of its trailing four quarters, averaging a roughly 4% positive surprise. Continued outperformance in the Consulting segment and stable underlying growth in Risk and Insurance Services will be closely watched.
Regulatory approvals and integration of pending acquisitions are another focal point. The planned closures of the AltamarCAM and Alts Manager transactions in the second half of 2026 would extend Marsh's reach into alternative-asset advisory and wealth platforms, while the Asterra acquisition, completed on July 1, adds specialized capabilities.
Analyst sentiment has become more constructive. In May 2026, both Goldman Sachs and Citigroup upgraded the stock to Buy with $200 price targets. As of late April 2026, the average one-year price target stood near $208, with a range of roughly $181 to $248, according to Fintel data. At the same time, the consensus profile remains mixed, with many analysts holding a Neutral stance and firms such as Mizuho trimming targets to reflect softer P&C pricing. The trajectory of these ratings and price targets will likely hinge on whether margin and organic-growth trends stabilize.
Marsh's trajectory is tightly linked to the insurance pricing cycle and broader macroeconomic conditions. The property-and-casualty market has been transitioning into a softer rate environment, which pressures the commission-driven brokerage revenue that anchors the Risk and Insurance Services segment. However, rising risk complexity — driven by climate exposure, cyber threats, and supply-chain fragility — continues to support demand for advisory and risk-placement services.
Interest rates and inflation play a dual role. Lower short-term rates reduce fiduciary interest income on client funds, a modest but real earnings contributor. Meanwhile, persistent cost inflation, particularly in wages and benefits, has driven operating expenses up about 7% year over year in Q2 2026, outpacing revenue growth and constraining near-term margin expansion. Marsh's efforts to offset these pressures through its "Thrive" efficiency program — targeting $400 million in cumulative savings — will be central to protecting profitability.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders identify whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the coming week or month. It supports users in spotting developing trends, evaluating possible breakouts or reversals, and exploring predictions across a broad universe of tradable instruments, with searchable prediction categories, historical context, and alert-oriented functionality. For investors monitoring Marsh (MRSH) amid shifting P&C pricing and analyst revisions, this tool can add a data-driven layer to trend analysis. Explore the platform to see how its predictive insights may complement your research.
Looking toward 2026 and beyond, consensus expectations point to mid-single-digit growth. Analysts project 2026 adjusted EPS of roughly $10.44–$10.45, up about 7% year over year, on revenue near $28.5 billion, with 2027 estimates extending EPS toward approximately $11.41. These figures reflect a steady, capital-light compounding model rather than dramatic acceleration.
Several long-term themes warrant attention. The mainstreaming of AI across risk analytics and consulting could gradually shift Marsh's margin structure, provided the company can convert technology investment into billable advisory value. Continued M&A — pursued with discipline — remains a structural growth lever, though it contributes to a leveraged balance sheet that may limit flexibility if borrowing costs rise. Cost discipline, talent retention, and the successful integration of acquired platforms will determine whether margin expansion resumes after the current cost-driven compression.
Finally, Marsh's consistent capital-return policy — including a 10% dividend increase in 2026, marking a 17th consecutive year of increases — underscores management's confidence in cash-flow durability. The key question for the stock forecast is whether organic growth and margin stabilization can outpace a softening insurance pricing cycle and justify a premium valuation relative to financial-sector peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Industry InsuranceBrokersServices
A.I.dvisor indicates that over the last year, MRSH has been closely correlated with BRO. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRSH jumps, then BRO could also see price increases.
| Ticker / NAME | Correlation To MRSH | 1D Price Change % | ||
|---|---|---|---|---|
| MRSH | 100% | +0.66% | ||
| BRO - MRSH | 80% Closely correlated | +1.43% | ||
| AJG - MRSH | 78% Closely correlated | +1.63% | ||
| AON - MRSH | 77% Closely correlated | -0.30% | ||
| WTW - MRSH | 65% Loosely correlated | +1.17% | ||
| RYAN - MRSH | 58% Loosely correlated | +3.76% | ||
More | ||||
| Ticker / NAME | Correlation To MRSH | 1D Price Change % |
|---|---|---|
| MRSH | 100% | +0.66% |
| MRSH (4 stocks) | 90% Closely correlated | -1.94% |
| Insurance Brokers/Services (22 stocks) | 84% Closely correlated | -0.79% |
| Insurance (119 stocks) | 62% Loosely correlated | +0.58% |
MRSH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 36 cases where MRSH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 69%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MRSH's RSI Oscillator exited the oversold zone, 17 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 58 cases where MRSH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 168 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
The Momentum Indicator moved below the 0 level on September 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRSH as a result. In 40 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
MRSH moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRSH crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 38%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
The Aroon Indicator for MRSH entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. MRSH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.313) is normal, around the industry mean (6.334). P/E Ratio (20.639) is within average values for comparable stocks, (32.709). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.022) settles around the average of (0.010) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (2.968).
The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.